Eli Lilly to seek approval of Alzheimer’s drug on same FDA pathway as Aduhelm
https://medcitynews.com/2021/06/eli-lilly-to-seek-approval-of-alzheimers-drug-on-same-fda-pathway-as-aduhelm/
Eight examples of humanism in action during COVID-19 and the global racial reckoning [Sponsored]
https://medcitynews.com/2021/06/eight-examples-of-humanism-in-action-during-covid-19-and-the-global-racial-reckoning/
mRNA startup Strand Therapeutics lands $52M to “program” new cancer therapies
https://medcitynews.com/2021/06/mrna-startup-strand-therapeutics-lands-52m-to-program-new-cancer-therapies/
Priority Health to leverage data, partnerships for new social determinants initiative
https://medcitynews.com/2021/06/priority-healths-new-social-determinants-initiative-to-leverage-data-partnerships/
Popular sepsis prediction model works ‘substantially worse’ than claimed, researchers find
https://medcitynews.com/2021/06/popular-sepsis-prediction-model-works-substantially-worse-than-claimed-researchers-find/
Mobile EHR startup DrChrono raises $12M, plans to build out telehealth features
https://medcitynews.com/2021/06/mobile-ehr-startup-drchrono-raises-12m-plans-to-build-out-telehealth-features/
Scripps Health hit by 4 class-action lawsuits on heels of ransomware attack
https://medcitynews.com/2021/06/scripps-health-hit-by-4-class-action-lawsuits-on-heels-of-ransomware-attack/
Third Rock-backed Abata gets $95M to take cell therapy to MS, other autoimmune diseases
https://medcitynews.com/2021/06/third-rock-backed-abata-gets-95m-to-take-cell-therapy-to-ms-other-autoimmune-diseases/
Pear Therapeutics plans to go public in $1.6B SPAC deal
https://medcitynews.com/2021/06/pear-therapeutics-plans-to-go-public-in-1-6b-spac-deal/
Remote Patient Monitoring: Coming of age in an AI-driven world
https://medcitynews.com/2021/06/remote-patient-monitoring-coming-of-age-in-an-ai-driven-world/
